NCT06930690View on ClinicalTrials.gov

Dexamethasone for Ureteral STent Symptoms (DUSTS)

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Ureteral Stent-Related Symptom
Interventions
DRUG

Dexamethasone Sodium Phosphate Injection

One time dose of dexamethasone sodium phosphate given intravenously at the time of surgery

Trial Locations (1)

77005

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT06930690 - Dexamethasone for Ureteral STent Symptoms (DUSTS) | Biotech Hunter | Biotech Hunter